Sector portfolio · Growth fund
Johnson & Johnson Innovation's Biotech portfolio
Johnson & Johnson Innovation has backed 10 Biotech startups in rounds we track, $1.4B between them, shown by the stage each has reached. The best-funded is Cvrx.
Funding by segment
- Series B$675M6
- Series C and later$735M4
Where they are based
- United States5$839M
- United Kingdom3$449M
- Canada1$105M
- China1$17M
United States
United Kingdom
Canada
ChinaFounded
3 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M1
- $50M to $250M7
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
7 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States5
- United Kingdom3
- Canada1
- China1
Startups by country, 4 countries in all.
Segment by segment
Series B
6 startups · $675M raised
T-TherapeuticsT-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.United Kingdom$279M
SonoTheraSonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies.United States$125M- FPFusion PharamaceuticalsCanada$105M
BlackThorn TherapeuticsBlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.United States$90M- IInivataUnited Kingdom$59M
- XLXW LabsChina$17M
Series C and later
4 startups · $735M raised
CVRxCVRx is a medical device company developing implantable technology for the treatment of high blood pressure.United States$369M
CereVascCereVasc is a clinical-stage medical device company based in Boston, Massachusetts, focused on developing innovative, minimally inUnited States$155M- AGAtlas GeneticsUnited Kingdom$111M
Torax MedicalTorax Medical develops an implantable device for the treatment of gastroesophageal reflux disease.United States$101M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Johnson & Johnson Innovation as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Johnson & Johnson Innovation?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.